Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-24-002889
Filing Date
2024-08-29
Accepted
2024-08-29 16:40:24
Documents
1
Period of Report
2024-08-27

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3139
  Complete submission text file 0001178913-24-002889.txt   4630
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Issuer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address KIRYAT HADASSAH MINRAV BUILDING, FIFTH FLOOR JERUSALEM L3 9112002
Business Address
Malca Yonatan (Reporting) CIK: 0001904759 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38556 | Film No.: 241264329